PharmD Info

A forum for Indian Pharmacy Professionals

New Drug Information's and other safety information, drug label changes, and Dose and Dosage Calculations, CDCSO,PvPI and FDA Safety Alerts and etc.
Forum rules: The material, content provided by this forum is for informational purpose only and is not intended for substitute to medical advice, diagnosis or treatment.General rules are applicable for this forum- Find Here
  • User avatar
#2862
The first medicine designed to prevent migraines was approved by the Food and Drug Administration on Thursday, ushering in what many experts believe will be a new era in treatment for people who suffer the most severe form of these headaches.

The drug, Aimovig, made by Amgen and Novartis, is a monthly injection with a device similar to an insulin pen. The list price will be $6,900 a year, and Amgen said the drug will be available to patients within a week.

References:

https://www.fda.gov/newsevents/newsroom ... 608120.htm
Similar Topics
Topics Statistics Last post
0 Replies 
515 Views
by Admin
0 Replies 
1218 Views
by Srikanthpm
0 Replies 
1428 Views
by Swathi Swaroopa B
0 Replies 
260 Views
by Admin
0 Replies 
1000 Views
by Swathi Swaroopa B

In recent years, the PharmD program has gained sig[…]

In today's dynamic healthcare landscape, pharmacis[…]

Are you aspiring to pursue a Master of Pharmacy (M[…]

PharmD Info - Highlights